|
WO2009075862A1
|
|
Method of assessing viability of embryos in vitro
|
|
WO2009075863A2
|
|
Method for diagnosing stroke
|
|
WO2009064492A1
|
|
Quinoline compounds as melanogenesis modifiers and uses thereof
|
|
WO2009064493A1
|
|
Tricyclic compounds as melanogenesis modifiers and uses thereof
|
|
WO2009061516A1
|
|
Medical implants containing adenosine receptor agonists and methods for inhibiting medical implant loosening
|
|
WO2009055021A1
|
|
Methods and compositions for treating hepatic diseases
|
|
WO2009042110A1
|
|
Bioactive graded ceramic-based structures
|
|
WO2009032288A1
|
|
Methods for predicting embryo viability
|
|
WO2008147540A1
|
|
S-triazine compounds, pharmaceutical compositions and methods of using the same
|
|
WO2009025691A1
|
|
Dendrimeric peptides, pharmaceutical compositions and methods of using the same
|
|
US2006246476A1
|
|
Methods for detecting circulating mutant BRAF DNA
|
|
US7250569B2
|
|
Method for dissolving nanostructural materials
|
|
WO0220849A2
|
|
Gene markers useful for detecting skin damage in response to ultraviolet radiation
|
|
US2002037934A1
|
|
Method for treating hepatitis
|
|
US6739335B1
|
|
Method and apparatus for optimizing controlled positive airway pressure using the detection of cardiogenic oscillations
|
|
AU7087000A
|
|
Crystal structures of domains of receptor protein tyrosine kinases and their ligands
|
